Latest Articles

Publication Date
GSK gets expanded EU approval for Jemperli in endometrial cancer - MSN

GSK gets expanded EU approval for Jemperli in endometrial cancer MSN

Published: Jan. 21, 2025, 7:31 p.m.
EU approves endometrial, lung cancer drugs from GSK and J&J - pharmaphorum

EU approves endometrial, lung cancer drugs from GSK and J&J pharmaphorum

Published: Jan. 21, 2025, 1:59 p.m.
GSK’s Jemperli Gains Expanded EU Approval for Endometrial Cancer - TipRanks

GSK’s Jemperli Gains Expanded EU Approval for Endometrial Cancer TipRanks

Published: Jan. 21, 2025, 12:20 p.m.
EC approves GSK’s Jemperli-chemo combo for endometrial cancer - Pharmaceutical Technology

EC approves GSK’s Jemperli-chemo combo for endometrial cancer Pharmaceutical Technology

Published: Jan. 21, 2025, 9:35 a.m.
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post

European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post

Published: Jan. 21, 2025, 4:36 a.m.
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer - Cancer Network

Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer Cancer Network

Published: Jan. 20, 2025, 5:08 p.m.
Bindi Irwin Cried ‘Happy Tears’ Over This Health Milestone - Taste of Country

Bindi Irwin Cried ‘Happy Tears’ Over This Health Milestone Taste of Country

Published: Jan. 20, 2025, 3:41 p.m.
Bindi Irwin Cried ‘Happy Tears’ Over This Health Milestone - catcountry1073.com

Bindi Irwin Cried ‘Happy Tears’ Over This Health Milestone catcountry1073.com

Published: Jan. 20, 2025, 3:41 p.m.
Bindi Irwin Cried ‘Happy Tears’ Over This Health Milestone - K99

Bindi Irwin Cried ‘Happy Tears’ Over This Health Milestone K99

Published: Jan. 20, 2025, 3:41 p.m.
Bindi Irwin Cried ‘Happy Tears’ Over This Health Milestone - LoneStar 92.3

Bindi Irwin Cried ‘Happy Tears’ Over This Health Milestone LoneStar 92.3

Published: Jan. 20, 2025, 3:41 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!